Technical Analysis for CERC - Cerecor Inc.

Grade Last Price % Change Price Change
grade C 4.98 -1.19% -0.06
CERC closed down 1.19 percent on Friday, May 24, 2019, on 68 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical CERC trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -1.19%
MACD Bearish Signal Line Cross Bearish -1.19%
Down 3 Days in a Row Weakness -1.19%
Down 4 Days in a Row Weakness -1.19%
20 DMA Resistance Bearish -4.23%

Older signals for CERC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cerecor, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs for the treatment of patients with neurological and psychiatric disorders. The company has a portfolio of clinical and preclinical compounds, such as CERC-301, CERC-501, and CERC-406. It develops CERC-301 that is in Phase II development stage as an oral, adjunctive antidepressant for the treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development, for co-occurring psychiatric and substance use disorders; and CERC-406 that is its preclinical lead candidate that inhibit catechol-O-methyltransferase within the brain, as well as anticipates developing CERC-406 for the treatment of residual cognitive impairment symptoms in patients with MDD. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor, Inc. was founded in 2011 and is headquartered in Baltimore, Maryland.
Chemistry Biopharmaceutical Disorders Organic Chemistry Depression Major Depressive Disorder Pyrrolidines Antidepressants Piperidines Nmda Receptor Antagonists
Is CERC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.65
52 Week Low 2.71
Average Volume 96,437
200-Day Moving Average 4.7039
50-Day Moving Average 5.465
20-Day Moving Average 5.2605
10-Day Moving Average 5.221
Average True Range 0.3222
ADX 19.01
+DI 13.9511
-DI 28.5249
Chandelier Exit (Long, 3 ATRs ) 4.8134
Chandelier Exit (Short, 3 ATRs ) 5.7166
Upper Bollinger Band 5.6624
Lower Bollinger Band 4.8586
Percent B (%b) 0.15
BandWidth 15.279916
MACD Line -0.0924
MACD Signal Line -0.0782
MACD Histogram -0.0142
Fundamentals Value
Market Cap 129.73 Million
Num Shares 26.1 Million
EPS -1.12
Price-to-Earnings (P/E) Ratio -4.45
Price-to-Sales 24.44
Price-to-Book 4.41
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.22
Resistance 3 (R3) 5.22 5.15 5.18
Resistance 2 (R2) 5.15 5.09 5.15 5.17
Resistance 1 (R1) 5.06 5.05 5.03 5.06 5.15
Pivot Point 4.99 4.99 4.97 4.99 4.99
Support 1 (S1) 4.90 4.93 4.87 4.90 4.81
Support 2 (S2) 4.83 4.89 4.83 4.79
Support 3 (S3) 4.74 4.83 4.78
Support 4 (S4) 4.74